Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
OptiBiotix Health ( (GB:OPTI) ) has shared an update.
OptiBiotix Health plc has issued 358,772 options over new ordinary shares to Director Sofia Kolyda, with an exercise price of 11 pence per share. The options, which expire in 2035, are part of the company’s strategic initiatives to incentivize leadership and align with its commercial goals, particularly in securing significant revenue-generating partnerships for its SweetBiotix products.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks, with a focus on areas such as obesity, cardiovascular health, and diabetes.
Average Trading Volume: 316,539
Technical Sentiment Signal: Sell
Current Market Cap: £11.62M
See more data about OPTI stock on TipRanks’ Stock Analysis page.